Customs key to big-fish counterfeiters: 3M counsel

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Customs key to big-fish counterfeiters: 3M counsel

Sponsored by

incopro.png
sebastian-pena-lambarri-abj-zuko6mg-unsplash.jpg

Hosted by Managing IP’s Ed Conlon, the discussion at Incopro’s Insync Virtual Summit explored how the pandemic has affected brand protection teams and offered key insights to drive success in 2021

The chief trademark counsel at 3M told an industry conference last month that brand owners must work closely with customs officials to reel in big-fish counterfeiters.

Colette Durst was speaking on a panel at Incopro’s Insync Virtual Summit on Thursday, January 28, alongside Jennifer Ehrlich, a strategic communications leader at 3M.

Durst, whom Managing IP also interviewed in late January, told the conference that brands should be prepared to do more with less in 2021 as budgets remain tight.

It came as a poll during the panel showed that nearly 50% of respondents have a smaller budget than at this time last year, while 34% said theirs had not changed. A further 19% said their budget has actually increased.

Durst and Ehrlich were reliving events from a year in which 3M’s workload has increased hugely. The company, which specialises in worker safety and healthcare, was put on the COVID frontline in early 2020 as demand for its N95 respirators soared.

At the same time, 3M witnessed a surge in trademark infringement, counterfeiting and fraud, particularly online. It responded by taking legal action and boosting communicating efforts, with 3M’s related in-house teams joining forces.

The IP team has also worked with law enforcement to stamp out counterfeiters, and Durst praised officials as “incredibly collaborative”. She said 3M will continue its work with the authorities, especially on large-sized cases.

3M has also used online and customs enforcement to make it harder for counterfeiters to get counterfeit respirators delivered to consumers. 

For the “big fish”, as she put it, Durst recommended using customs to block goods from entering a country and using the shipment data to track down the offenders. “That has been incredibly helpful,” she said.

Durst added that 3M is continuing to look at how else it can identify the big fish, including by using technology tools, even as the IP team does more with less in 2021.

For further examples of 3M’s communication efforts, please see: www.3m.com/covidfraud

To learn more about the panel, which was hosted by Managing IP’s managing editor Ed Conlon, please see the recording on the Insync website.

more from across site and SHARED ros bottom lb

More from across our site

Niri Shan, the newly appointed head of IP for UK, Ireland and the Middle East, explains why the firm’s international setup has brought UPC success, and addresses German partner departures
Vlad Stanese joins our ‘Five minutes with’ series to discuss potentially precedent-setting trademark and copyright cases and his love for aviation
Heath Hoglund, president of Via LA, discusses how it sets royalty rates and its plans to build on growth in China
Stobbs stands accused of interfering with the administration of justice after Brandsmiths’ client was subjected to an interim injunction for unjustified threats
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
Ed White at Clarivate provides an exclusive insight into the innovation power clusters reshaping Europe and the Middle East’s IP landscape, and why quality is the new currency of invention
In the first in a new podcast series celebrating the tenth anniversary of IP Inclusive, we look back at the network’s origins and discuss its mission
Rebecca Schwarz at Haynes Boone shares how her team secured victory for biopharma client RedHill in a licensing dispute involving a developmental cancer drug
News of a breakaway firm launching in Germany and a spike in vaccine-related patent applications were also among the top talking points
A flurry of hiring activity among UK firms suggests they are confident of mounting a serious challenge at the UPC
Gift this article